Moderna Reports Second Quarter 2023 Financial Results and ...

Revenue: Total revenue for the second quarter of 2023 was $344 million, compared to $4.7 billion in the same period in 2022, mainly due to a ...

Moderna Reports Second Quarter 2024 Financial Results and ...

Revenue: Total revenue for the second quarter of 2024 was $241 million, compared to $344 million in the same period in 2023. This decline was ...

Quarterly Results - Moderna

Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates · Reports third quarter revenues of $1.9 billion, GAAP net income of $13 ...

Moderna Reports Second Quarter 2023 Financial Results and ...

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial ...

Moderna (MRNA) Q2 earnings report 2023 - CNBC

Moderna raises Covid vaccine outlook despite sharp drop in quarterly sales · Loss per share: $3.62, vs. $4.04 expected · Revenue: $344 million, ...

Moderna Reports Second Quarter 2023 Financial Results and ...

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, today reported financial results and provided business updates ...

Moderna to Report Second Quarter 2023 Financial Results on ...

Moderna to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023 · CAMBRIDGE, MA / ACCESSWIRE / July 13, 2023 / · About Moderna.

Moderna Reports Second Quarter 2024 Financial Results and ...

Reports second quarter revenues of $241 million, GAAP net loss of $1.3 billion and GAAP EPS of $(3.33) Updates 2024 financial framework and ...

Moderna Reports Second Quarter 2024 Financial Results and ...

Revenue declined to $241 million , down from $344 million in Q2 2023, primarily due to decreased COVID-19 vaccine sales. The company reported a ...

Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial ...

The Company is reaffirming its 2024 product sales outlook as it enters the second year of the U.S. commercial endemic COVID market with ...

Arbutus Reports Second Quarter 2024 Financial Results and ...

As of June 30, 2024, the Company had cash, cash equivalents and investments in marketable securities of $148.5 million compared to $132.3 million as of December ...

Novavax Reports Second Quarter 2024 Financial Results and ...

Total revenue for the second quarter of 2024 was $415 million, compared to $424 million in the same period in 2023. · Cost of sales for the ...

Moderna Reports Second Quarter 2024 Financial Results ... - Reddit

Forecasted sales of $4bn cut to $3-3.5bn, a fall of 12.5-25%, is obviously disappointing for short term investors / the market. Personally I'd ...

Moderna (MRNA) earnings Q2 2024 - CNBC

Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance of $4 billion.

Vertex Reports Second Quarter 2023 Financial Results

Net product revenue in the second quarter of 2023 increased 7% to $1.51 billion in the U.S. and increased 26% to $985 million outside the U.S. , ...

Carisma Therapeutics Reports Second Quarter 2024 Financial ...

("Moderna"). The development candidate is an in vivo chimeric antigen receptor macrophage and monocyte, or CAR-M, targeting Glypican-3 and is ...

News and Blog Posts - Moderna

Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates ... Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results ...

Merck Announces Second-Quarter 2023 Financial Results

Merck now expects full-year sales to be between $58.6 billion and $59.6 billion, including a negative impact of foreign exchange of ...

Moderna Reports Second Quarter 2024 Financial Results and ...

Moderna, Inc. reports Q2 revenues of $241 million, GAAP net loss of $1.3 billion. Updates 2024 financial framework and expects product sales ...

Moderna Reports Third Quarter 2024 Financial Results ... - KGET.com

Revenue: Total revenue for the third quarter of 2024 was $1.9 billion, compared to $1.8 billion in the same period in 2023. Net product sales ...